UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Discrepancies between genitourinary cancer patients' and clinicians' characterization of the Eastern Cooperative Oncology Group performance status

Cancer, 2021-02, Vol.127 (3), p.354-358

2021

Volltextzugriff (PDF)

Clinical activity of nivolumab in patients with non-clear cell renal cell carcinoma

Journal for immunotherapy of cancer, 2018-01, Vol.6 (1), p.9-9, Article 9

2018

Volltextzugriff (PDF)

Reduced T-cell Numbers and Elevated Levels of Immunomodulatory Cytokines in Metastatic Prostate Cancer Patients De Novo Resistant to Abiraterone and/or Enzalutamide Therapy

International journal of molecular sciences, 2019-04, Vol.20 (8), p.1831

2019

Volltextzugriff (PDF)

Endothelial cell FGF signaling is required for injury response but not for vascular homeostasis

Proceedings of the National Academy of Sciences - PNAS, 2014-09, Vol.111 (37), p.13379-13384

2014

Volltextzugriff (PDF)

Aspirin use and long-term rates of sepsis: A population-based cohort study

PloS one, 2018-04, Vol.13 (4), p.e0194829

2018

Volltextzugriff (PDF)

The multicopper ferroxidase hephaestin enhances intestinal iron absorption in mice

PloS one, 2014-06, Vol.9 (6), p.e98792

2014

Volltextzugriff (PDF)

Targeting STAT3 in tumor-associated antigen-presenting cells as a strategy for kidney and bladder cancer immunotherapy

Frontiers in immunology, 2024-01, Vol.14, p.1274781-1274781

2024

Volltextzugriff (PDF)

Correlates of clinical benefit from immunotherapy and targeted therapy in metastatic renal cell carcinoma: comprehensive genomic and transcriptomic analysis

Journal for immunotherapy of cancer, 2020-07, Vol.8 (2), p.e000953

2020

Volltextzugriff (PDF)

Prevalence of Dietary Modification and Supplement Use in Patients with Metastatic Renal Cell Carcinoma Receiving Systemic Therapy

Nutrients, 2024-05, Vol.16 (11), p.1630

2024

Volltextzugriff (PDF)

Characterizing the relationships between tertiary and community cancer providers: Results from a survey of medical oncologists in Southern California

Cancer medicine (Malden, MA), 2021-08, Vol.10 (16), p.5671-5680

2021

Volltextzugriff (PDF)

541 Investigating myeloid derived suppressor cells (MDSCs) and oligonucleotide based targeting of STAT3 in renal cell carcinoma

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A577-A577

2020

Volltextzugriff (PDF)

Vitamin K epoxide reductase expression and prostate cancer risk

Urologic oncology, 2017-03, Vol.35 (3), p.112.e13-112.e18

2017

Volltextzugriff (PDF)

Impact of modern chemotherapy on the survival of women presenting with de novo metastatic breast cancer

BMC cancer, 2012-09, Vol.12 (1), p.435-435, Article 435

2012

Volltextzugriff (PDF)

645 Preclinical development of a novel colon-targeted therapeutic for the treatment of immune checkpoint inhibitor (ICI)-colitis

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A682-A682

2020

Volltextzugriff (PDF)

Stool Microbiome Profiling of Patients with Metastatic Renal Cell Carcinoma Receiving Anti–PD-1 Immune Checkpoint Inhibitors

European urology, 2020-10, Vol.78 (4), p.498-502

2020

Volltextzugriff (PDF)

Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial

Nature medicine, 2022-04, Vol.28 (4), p.704-712

2022

Volltextzugriff (PDF)

Whirlpool sign on ultrasound in testicular torsion

Visual journal of emergency medicine, 2021-01, Vol.22, p.100985, Article 100985

2021

Volltextzugriff (PDF)

National characteristics of Emergency Department visits by patients with cancer in the United States

The American journal of emergency medicine, 2018-11, Vol.36 (11), p.2038-2043

2018

Volltextzugriff (PDF)

A phase I trial to assess the biologic effect of CBM588 ( Clostridium butyricum ) in combination with nivolumab plus ipilimumab (nivo/ipi) in patients with metastatic renal cell carcinoma (mRCC)

Journal of clinical oncology, 2020-02, Vol.38 (6_suppl), p.TPS764-TPS764

2020

Volltextzugriff (PDF)

Progression-free survival (PFS) and overall survival (OS) across ethnicities for patients with metastatic renal cell carcinoma (mRCC) receiving targeted therapies (TT) as first-line (1L) treatment

Journal of clinical oncology, 2020-02, Vol.38 (6_suppl), p.645-645

2020

Volltextzugriff (PDF)

Impact of Latino ethnicity on the gut microbiome composition of patients with metastatic renal cell cancer (mRCC)

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.4521-4521

2024

Volltextzugriff (PDF)

Stool Bacteriomic Profiling in Patients with Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor-Tyrosine Kinase Inhibitors

Clinical cancer research, 2015-12, Vol.21 (23), p.5286-5293

2015

Volltextzugriff (PDF)

Efficacy of systemic treatment for metastatic renal cell carcinoma (mRCC) guided by comprehensive genomic profiling (CGP)

Journal of clinical oncology, 2019-09, Vol.37 (27_suppl), p.63-63

2019

Volltextzugriff (PDF)

77 Impact of CBM588 on gut microbiome composition and dysbiosis in patients receiving frontline immune checkpoint inhibitor (ICI) combinations for metastatic renal cell carcinoma (mRCC)

The oncologist (Dayton, Ohio), 2024-08, Vol.29 (Supplement_1), p.S5-S5

2024

Volltextzugriff (PDF)

1 – 25 von 203

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(199)
Mit Volltextzugriff
(178)

Publikationsform

Artikel
(202)
Buchkapitel
(1)

Sprache

Englisch
(203)

Erscheinungsjahr

n.n

Thema

Science & Technology
(110)
Life Sciences & Biomedicine
(106)
Humans
(82)
Female
(52)
Male
(46)
Aged
(41)
Middle Aged
(40)
Oncology
(36)
Aged, 80 And Over
(22)
Ophthalmology
(21)
Adult
(19)
Urology & Nephrology
(18)
Angiogenesis Inhibitors - Therapeutic Use
(17)
Prospective Studies
(17)
Renal Cell Carcinoma
(17)
Patients
(16)
Immunotherapy
(15)
Kidney Cancer
(15)
Treatment Outcome
(15)
Bevacizumab
(13)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Discrepancies between genitourinary cancer patients' and clinicians' characterization of the Eastern Cooperative Oncology Group performance status

Clinical activity of nivolumab in patients with non-clear cell renal cell carcinoma

Reduced T-cell Numbers and Elevated Levels of Immunomodulatory Cytokines in Metastatic Prostate Cancer Patients De Novo Resistant to Abiraterone and/or Enzalutamide Therapy

Endothelial cell FGF signaling is required for injury response but not for vascular homeostasis

Aspirin use and long-term rates of sepsis: A population-based cohort study

The multicopper ferroxidase hephaestin enhances intestinal iron absorption in mice

Targeting STAT3 in tumor-associated antigen-presenting cells as a strategy for kidney and bladder cancer immunotherapy

Correlates of clinical benefit from immunotherapy and targeted therapy in metastatic renal cell carcinoma: comprehensive genomic and transcriptomic analysis

Prevalence of Dietary Modification and Supplement Use in Patients with Metastatic Renal Cell Carcinoma Receiving Systemic Therapy

Characterizing the relationships between tertiary and community cancer providers: Results from a survey of medical oncologists in Southern California

541 Investigating myeloid derived suppressor cells (MDSCs) and oligonucleotide based targeting of STAT3 in renal cell carcinoma

Vitamin K epoxide reductase expression and prostate cancer risk

Impact of modern chemotherapy on the survival of women presenting with de novo metastatic breast cancer

645 Preclinical development of a novel colon-targeted therapeutic for the treatment of immune checkpoint inhibitor (ICI)-colitis

Stool Microbiome Profiling of Patients with Metastatic Renal Cell Carcinoma Receiving Anti–PD-1 Immune Checkpoint Inhibitors

Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial

Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study

Whirlpool sign on ultrasound in testicular torsion

National characteristics of Emergency Department visits by patients with cancer in the United States

A phase I trial to assess the biologic effect of CBM588 ( Clostridium butyricum ) in combination with nivolumab plus ipilimumab (nivo/ipi) in patients with metastatic renal cell carcinoma (mRCC)

Progression-free survival (PFS) and overall survival (OS) across ethnicities for patients with metastatic renal cell carcinoma (mRCC) receiving targeted therapies (TT) as first-line (1L) treatment

Impact of Latino ethnicity on the gut microbiome composition of patients with metastatic renal cell cancer (mRCC)

Stool Bacteriomic Profiling in Patients with Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor-Tyrosine Kinase Inhibitors

Efficacy of systemic treatment for metastatic renal cell carcinoma (mRCC) guided by comprehensive genomic profiling (CGP)

77 Impact of CBM588 on gut microbiome composition and dysbiosis in patients receiving frontline immune checkpoint inhibitor (ICI) combinations for metastatic renal cell carcinoma (mRCC)

Suchergebnisse filtern